eISSN: 2077-9135 / ISSN: 1681-5491
Register
Login
Medical Channel Journal
2023, Volume 29, Issue 3
Research Article
Efficacy of PRP in hair restoration – A study of 50 patients
Received
April 24, 2024
Revised
May 1, 2024
Accepted
June 12, 2024
Published
Aug. 4, 2024
Abstract

Background: Hair loss is a prevalent concern affecting a significant portion of the population. While various treatments exist, their efficacy varies, prompting the exploration of alternative interventions. Platelet Rich Plasma (PRP) therapy, a novel approach gaining popularity, involves injecting a patient’s processed blood, rich in concentrated platelets containing growth factors, into the scalp to stimulate hair growth. Objective: This multi-centre study aimed to rigorously investigate the effectiveness of PRP therapy in hair restoration by conducting a comprehensive analysis of outcomes. Methods: The study enrolled 50 patients experiencing hair loss, who underwent PRP therapy at private setups. This procedure included drawing the patient’s blood, processing it to concentrate platelets, and subsequently injecting them into the scalp. The patients were closely monitored for six months to 1 year, and the results were meticulously analysed using statistical methods. Results: The study revealed significant improvements in hair density, thickness, and overall coverage in the majority of patients subjected to PRP therapy. These outcomes were consistent with previous research, positioning PRP therapy as an effective intervention for hair restoration. Conclusion: The findings of this study underscore the efficacy of PRP therapy in addressing hair loss. The positive results, coupled with its minimally invasive nature, make PRP therapy a promising option for individuals seeking effective hair restoration. Further research and larger scale studies are warranted to validate these findings and refine treatment protocols.

License
Copyright (c) Medical Channel Journal
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Med. Channel J. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Medical Channel Journal
support@medicalchanneljournal.pk
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©Medical Channel Journal. All rights reserved.
|
|
|